Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hemostemix Inc (HMTXF)

Hemostemix Inc (HMTXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0573 +10.65%
on 12/03/25
0.0700 -9.43%
on 12/12/25
+0.0024 (+3.93%)
since 11/13/25
3-Month
0.0573 +10.65%
on 12/03/25
0.0878 -27.79%
on 10/07/25
-0.0106 (-14.32%)
since 09/15/25
52-Week
0.0464 +36.64%
on 12/17/24
0.2850 -77.75%
on 01/24/25
+0.0196 (+44.75%)
since 12/11/24

Most Recent Stories

More News
Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)

Thomas Smeenk, BA, unveils a proposed conformal invariant, A = E/(hv), explored as a potential bridge between General Relativity, Quantum Mechanics, cosmology, and string theory.Calgary, Alberta--(Newsfile...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix Grants Stock Options

Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce that in accordance with its stock...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000

Calgary, Alberta--(Newsfile Corp. - December 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), the leading autologous (patient's own) stem cell therapy...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix Welcomes Shaune Harding, OStJ, RN as Director of Patient Care & Clinical Operations

Calgary, Alberta--(Newsfile Corp. - December 4, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), a leader in autologous stem cell therapeutics for ischemic...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14

Calgary, Alberta--(Newsfile Corp. - December 3, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce its participation as a premier regenerative...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix to Attend DFCon San Antonio and Closed its Private Placement

Calgary, Alberta--(Newsfile Corp. - December 2, 2025) - Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is proud to announce its participation in DFCon 2025, hosted by the American Limb Preservation...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring its First Two

Calgary, Alberta--(Newsfile Corp. - November 26, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), is pleased to announce a binding Letter of Intent for the acquisition of the first two cardiology...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia

Calgary, Alberta--(Newsfile Corp. - November 20, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCellâ„¢ (ACP-01)...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix Closes CDN$280,594 Private Placement

Calgary, Alberta--(Newsfile Corp. - November 18, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"), the leading autologous (patient's own) stem cell therapy...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)
Hemostemix to Showcase Breakthrough Wound Healing Therapy at Innovations in Wound Care Conference Florida

Calgary, Alberta--(Newsfile Corp. - November 18, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), a leader in regenerative medicine, will attend the Innovations in Wound Care Conference...

HMTXF : 0.0634 (-9.43%)
HEM.VN : 0.090 (-5.26%)

Key Turning Points

3rd Resistance Point 0.0641
2nd Resistance Point 0.0637
1st Resistance Point 0.0636
Last Price 0.0634
1st Support Level 0.0631
2nd Support Level 0.0627
3rd Support Level 0.0626

See More

52-Week High 0.2850
Fibonacci 61.8% 0.1939
Fibonacci 50% 0.1657
Fibonacci 38.2% 0.1375
Last Price 0.0634
52-Week Low 0.0464

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar